GB1058340A - Transmissible gastroenteritis vaccines and method of producing the same - Google Patents

Transmissible gastroenteritis vaccines and method of producing the same

Info

Publication number
GB1058340A
GB1058340A GB40379/65A GB4037965A GB1058340A GB 1058340 A GB1058340 A GB 1058340A GB 40379/65 A GB40379/65 A GB 40379/65A GB 4037965 A GB4037965 A GB 4037965A GB 1058340 A GB1058340 A GB 1058340A
Authority
GB
United Kingdom
Prior art keywords
virus
vaccine
sow
pigs
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB40379/65A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIAMOND LAB Inc
Original Assignee
DIAMOND LAB Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DIAMOND LAB Inc filed Critical DIAMOND LAB Inc
Publication of GB1058340A publication Critical patent/GB1058340A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225Porcine transmissible gastroenteritis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20061Methods of inactivation or attenuation
    • C12N2770/20064Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

In the production of transmissible gastro-enteritis (T.G.E.) virus vaccine, virulent particles of the virus are inoculated into a first tissue culture, the virus is incubated therein for a period up to 24 hours, preferably for from 6 to 14 hours, the viral particles are removed from the culture and inoculated into one or more further tissue cultures, and the incubation and inoculation into further tissue culture or cultures is repeated one or more times. The virus is obtained from the mucosa of the intestinal tracts of infected pigs. Tissues of swine, sheep, cattle, dogs, ferrets and cats may be employed; however, it is preferred to use dog kidney cells for each tissue culture. The incubation of the virulent virus is carried out at 35 DEG to 38 DEG C. The propagation of the virus may be continued until it is rendered avirulent. An inactivated vaccine may be prepared by combining a virus-containing culture with a stabilizing menstrum and incubating at 25 DEG C. for five days. The vaccine can be stored at a low temperature or freeze-dried. Sows and their nursing pigs can be immunized against transmissible gastro-enteritis virus by injecting the virus vaccine into the pregnant sow six weeks before farrowing, thereby stimulating the production of anti-bodies which protect the sow, and nursing the pigs on the sow thereby protecting them against the virus by way of anti-bodies passed in the milk.ALSO:In the production of transmissible gastroenteritis (T.G.E.) virus vaccine, virulent particles of the virus are inoculated into a first tissue culture, the virus is incubated therein for a period up to 24 hours, preferably for from 6 to 14 hours, the viral particles are removed from the culture and inoculated into one or more further tissue cultures, and the incubation and inoculation into further tissue culture or cultures is repeated one or more times. The virus is obtained from the mucosa of the p intestinal tracts of infected pigs. Tissues of swine, sheep, cattle, dogs, ferrets and cats may be employed; however, it is preferred to use dog kidney cells for each tissue culture. The incubation of the virulent virus is carried out at 35 DEG to 38 DEG C. The propagation of the virus may be continued until it is rendered avirulent. An inactivated vaccine may be prepared by combining a virus-containing culture with a stabilizing menstrum and incubating at 25 DEG C for five days. The vaccine can be stored at a low temperature or freeze-dried. Sows and their nursing pigs can be immunized against transmissible gastroenteritis virus by injecting the virus vaccine into the pregnant sow six weeks before farrowing, thereby stimulating the production of antibodies which protect the sow, and nursing the pigs on the sow thereby protecting them against the virus by way of antibodies passed in the milk.
GB40379/65A 1964-09-22 1965-09-22 Transmissible gastroenteritis vaccines and method of producing the same Expired GB1058340A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39839864A 1964-09-22 1964-09-22

Publications (1)

Publication Number Publication Date
GB1058340A true GB1058340A (en) 1967-02-08

Family

ID=23575249

Family Applications (1)

Application Number Title Priority Date Filing Date
GB40379/65A Expired GB1058340A (en) 1964-09-22 1965-09-22 Transmissible gastroenteritis vaccines and method of producing the same

Country Status (10)

Country Link
BE (1) BE669881A (en)
CH (1) CH466894A (en)
DE (1) DE1253412B (en)
DK (1) DK109407C (en)
FR (1) FR1563628A (en)
GB (1) GB1058340A (en)
LU (1) LU49501A1 (en)
NL (1) NL6512094A (en)
NO (1) NO119491B (en)
SE (1) SE358657B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519710A (en) * 1967-08-10 1970-07-07 Edmund P Bass Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth
EP0310316A2 (en) * 1987-09-28 1989-04-05 Beecham Inc. TGEV-virus of swine as a dog vaccine
US5911999A (en) * 1987-09-28 1999-06-15 Pfizer, Inc. Vaccine based on TGEV for protection of dogs against canine coronavirus
US6074651A (en) * 1988-09-14 2000-06-13 Pfizer, Inc. Vaccine based on TGEV for protection of canines against canine coronavirus

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519710A (en) * 1967-08-10 1970-07-07 Edmund P Bass Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth
EP0310316A2 (en) * 1987-09-28 1989-04-05 Beecham Inc. TGEV-virus of swine as a dog vaccine
EP0310316A3 (en) * 1987-09-28 1990-02-14 Beecham Inc. Novel vaccine
US5911999A (en) * 1987-09-28 1999-06-15 Pfizer, Inc. Vaccine based on TGEV for protection of dogs against canine coronavirus
US6074651A (en) * 1988-09-14 2000-06-13 Pfizer, Inc. Vaccine based on TGEV for protection of canines against canine coronavirus

Also Published As

Publication number Publication date
NO119491B (en) 1970-05-25
NL6512094A (en) 1966-03-23
DK109407C (en) 1968-04-22
BE669881A (en) 1966-03-21
CH466894A (en) 1968-12-31
SE358657B (en) 1973-08-06
LU49501A1 (en) 1966-03-21
DE1253412B (en) 1967-11-02
FR1563628A (en) 1969-04-18

Similar Documents

Publication Publication Date Title
Pye Vaccination of sheep with cell culture grown orf virus
US3127318A (en) Swine treatment
US3155589A (en) Parenteral extravascular injectable vaccines for simultaneous immunization of canidae against rabies, canine distemper, and infectious canine hepatitis
NO159782B (en) SPRING SYSTEM DEVICE, FIRST AND FIRST ON VEHICLES.
de Baugés et al. Effect of antibiotic therapy and strain-19 vaccination on the spread of Brucella melitensis within an infected dairy herd
Lawson et al. The ERA strain of rabies vaccine
ES373631A1 (en) Live attenuated marek{40 s disease virus vaccine for poultry
GB1058340A (en) Transmissible gastroenteritis vaccines and method of producing the same
IE46498B1 (en) New vaccine
US3479430A (en) Indirect passive immunization against transmissible gastroenteritis virus in nursing piglets at birth by active immunization of sows prior to farrowing with transmissible gastroenteritis vaccine and method of producing the same
Owen et al. Bluetongue in cattle: typing of viruses isolated from cattle exposed to natural infections
US3562387A (en) Mink virus enteritis vaccine and method for the production thereof
US3585108A (en) Transmissible gastroenteritis vaccines and methods of producing the same
US3000788A (en) Propagation of modified infectious canine hepatitis virus in tissue cultures of pig kidney and the preparation of a vaccine therefrom
US3704203A (en) Transmissible gastroenteritis vaccines and methods of producing the same
Thorsen et al. Experimental immunization of sows with inactivated transmissible gastroenteritis (TGE) virus
Haig Further observations on the growth of Green's distemperoid virus in developing hen eggs
Caldwell Beef cattle reproductive herd health
US3725542A (en) Intramuscular vaccination program and vaccine against rhinopneumonitis and process for preparing it
US3122477A (en) Hog cholera vaccine and method of making the same
Dalsgaard et al. Saponin adjuvants. VI. The adjuvant activity of quil A in trivalent vaccination of cattle and guinea pigs against foot-and-mouth disease
US3096247A (en) Infectious rhinotracheitis virus attenuated in lamb cell tissue cultures
US2998349A (en) Vaccine against avian respiratory infection
RU2162340C1 (en) Method of preparing vaccine against salmonellosis in pigs
RU1459002C (en) Vaccine and method for preventing infectious hepatitis in carnivorous animals